| DESCRIPTION OF ENHANCEMENTS |
This patch is being released to address a few small eRx related issues
6. NDC code included in the Requested Medication section of the eRx Rx Change
Note: Aware of Allergy. Patient Tolerates
Qty: 30 Refills: 5 Days Supply: 180
Quantity Unit Of Measure: TABLET DOSING UNIT
Sig: TAKE 1 TAB PO DAILY
------------------------------------------------------------------------
7. Complete Orders from eRx [PSO ERX FINISH] option removal
--------------------------------------------------------------------------
The Complete Orders from eRx [PSO ERX FINISH] option was put Out-of-Order
by the PSO*7*746 patch because its functionality has been fully replaced
Request
by the eRx Holding Queue Processing [PSO ERX QUEUE PROCESSING] option.
This patch will now remove/delete this obsolete option from your menu.
8. SIG over 512 characters cause a <SUBSRCIPT> error
--------------------------------------------------------------------------
When the user tried to select the VistA drug to match the eRx drug and
a VistA suggestion exists with a SIG that is longer than 512 characters
they software throws a <SUBSCRIPT> error, which will be addressed by this
patch.
7. Complete Orders from eRx [PSO ERX FINISH] option removal
8. SIG over 512 characters cause a <SUBSRCIPT> error
1. Written Date with Time display issue
--------------------------------------------------------------------------
Some prescribers send eRx's with a timestamp for the Written Date and
this causes a display issue which overwrites the 'eRx Status' label as
shown below:
encountered after the patch PSO*7*746 was released:
Single eRx View/Display Aug 10, 2024@10:28:15 Page: 1 of 2
eRx Patient: PATIENT,TEST eRx Reference #: 999999999
eRx Msg Type: NEWRX Written: 08/23/24
@11:11:11s: W - WAIT
^^^^^^^^^
2. Changed ADDITIONAL NOTE TO PROVIDER prompt to SUGGESTED PROVIDER NOTE
(FOR RESPONSE RX) + Default for eRx drug selection
--------------------------------------------------------------------------
After verifying data from several Rx Responses from the prescriber it
was determined that the prompt ADDITIONAL NOTE TO PROVIDER was wrongly
worded. This field is not supposed to be used by Pharmacy to
communicate with the prescriber, the correct use is for pharmacy to
enter a suggested Provider Note content that the prescriber will then
decide to keep, change or delete when adopting the requested medication.
Additionally, when the user is building the requested medication, if the
user selects E (use eRx Drug) the Provider Notes content (if any) will
be given as default for the Provider Notes in the medication requested,
as shown below:
1. Written Date with Time display issue
SUGGESTED PROVIDER NOTE (FOR RESPONSE RX): Suggested Packaging: 2.0
Milliliters syringe. Replace ??
This is the suggested Provider Note that will be sent back with Rx
Response if this drug option is selected by the outside Provider. It
may be edited/removed by the Provider before sending the response
back.
3. View Suggestion(s) action fix
2. Changed ADDITIONAL NOTE TO PROVIDER prompt to SUGGESTED PROVIDER NOTE
--------------------------------------------------------------------------
Sometimes the VS (View Suggestion(s)) action does not show any suggestions
and does not say 'No suggestions found' either. This is being fixed with
this patch.
4. DUE (Drug Use Evaluation) Override Reason display issue
--------------------------------------------------------------------------
When the Override field from a DUE is longer than 28 characters it
'spills' over into the next section (VistA), as shown below:
(FOR RESPONSE RX) + Default for eRx drug selection
Prescriber Drug Use Evaluation: |________________________________
Co-Agent: |3)Patient Instructions:
Reason: Product Selection Opportunity |
Result: |
Override: Substitute as necessary, ple |
ase provide documentat|on to
patient for assistanc|
After fix:
---------
3. View Suggestion(s) action fix
Prescriber Drug Use Evaluation: |________________________________
Co-Agent: |3)Patient Instructions:
Reason: Product Selection Opportunity |
Result: |
Override: Substitute as necessary, plea|
se provide documentation to p|
atient for assistance |
5. Print action fixes
--------------------------------------------------------------------------
4. DUE (Drug Use Evaluation) Override Reason display issue
Two small changes were made to the Print action in the PATIENT INFORMATION
section:
- Fixed a misspelling of the label 'Nane:' to 'Name:'
- Changed label 'Primary Telephone' to 'Primary Phone'
6. NDC code included in the Requested Medication section of the eRx Rx Change
Request
--------------------------------------------------------------------------
Sometimes when an RX Change Request is sent the outside prescriber
software returns an error saying the drug suggested is not recognized.
5. Print action fixes
This issue happens when the user selects a VistA drug for the Requested
Medication and the VistA NDC for this drug is not recognized by the
prescriber software. In order to facilitate the troubleshooting of such
issue the NDC sent to the prescriber for the Requested Medication will
now be displayed in the Requested Medication of the Rx Change Request
section, as shown below:
--------------------------MEDICATION REQUESTED 1-------------------------
Drug: NAPROXEN 250MG TAB
Substitutions: YES NDC: 77771-0434-05
|
